What is the general market price range of Guanfacine?

Guanfacine is a prescription drug that acts on the central nervous system. It was originally developed to treat high blood pressure, but with the deepening of research, it has gradually shown clinical value in the management of attention deficit hyperactivity disorder (ADHD). Its main mechanism is to activate α2A adrenergic receptors in the brain to reduce the excessive release of neurotransmitters, thereby stabilizing neural activity and improving attention and impulse control.

Unlike traditional central stimulants, the use of guanfacine inADHD patients is considered to have a low risk of dependence, and is especially suitable for those who are intolerant to stimulants or suffer from anxiety and sleep disorders. Therefore, it is gradually being promoted in foreign markets. At the same time, guanfacine has also been explored for use in other neuropsychiatric diseases, such as anxiety disorders, post-traumatic stress disorder (PTSD), etc., but these studies are still in the clinical verification stage.

In China, the original drug of guanfacine is not yet on the market, so patients need to rely on overseas channels if they need to use it. The more common specifications in the Japanese market are 1 mg 140 tablets and 3 mg 140 tablets. The price is about 3,000 yuan. However, due to fluctuations in international exchange rates and differences in import channels, the actual purchase price will be different. There are currently no generic guanfacine drugs officially launched globally, which means there is insufficient market competition and it is difficult for prices to drop significantly in the short term.

Compared with some common psychotropic drugs, guanfacine has a higher acquisition cost, which limits its popularity among the general patient population. In the long term, if generic versions enter the market, it may significantly reduce the economic burden on patients and promote the clinical application of the drug in a wider range. For patients and their families who intend to use guanfacine, they need to make prudent decisions based on the financial situation of their doctors and families, and pay attention to the latest developments in the introduction of the drug in the country and medical insurance policies.

Reference materials:https://go.drugbank.com/drugs/DB01018